Tru

ChromaDex Corporation Reports First Quarter 2022 Financial Results

Retrieved on: 
Thursday, May 12, 2022
Health, Other Health, Other Science, Research, Science, Pharmaceutical, Biotechnology, Company, History, EBITDA, U.S. Securities and Exchange Commission, Phytochemical, ChromaDex, Webcast, Patient, Investment, News, NASDAQ, CERP, 250th Tunnelling Company, NAD, COVID-19, Marketing, Adjustment, Research, Securities Act of 1933, Securities Exchange Act of 1934, Awareness, Conference, Tru, Forward-looking statement, Human, Investor relations, Compte rendu, Ageing, Cell Metabolism, Security (finance), GAAP, PD, Twitter, NR, SEC, Growth, Human body, Replay, Clinical trial, Annual report, CEO, Pharmaceutical industry, Mobile phone, Communications satellite

ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2022.

Key Points: 
  • ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2022.
  • We delivered solid financial results in the first quarter, while strengthening our patent portfolio, and announcing dramatic new scientific research on Niagen(R), said CEO, Rob Fried.
  • Following the quarter, we launched Tru Niagen(R) Immune and ramped up our new TV campaign to encouraging early results.
  • Results of operations for the three months ended March 31, 2022 compared to the prior year quarter
    For the three months ended March 31, 2022 (Q1 2022), ChromaDex reported net sales of $17.3 million, up $2.6 million or 18% compared to the first quarter of 2021 (Q1 2021).

Slate Asset Management Provides $14.9 Million Loan Secured by Tru by Hilton Hotel in Dania Beach, FL

Retrieved on: 
Wednesday, May 4, 2022
Commercial Building & Real Estate, Construction & Property, Finance, REIT, Professional Services, Building Systems, Destinations, Vacation, Travel, Slate, Tru, Airport, Port Everglades, Hilton, Hilton Hotels & Resorts, Capital Group Companies, Industry, Fortification, AD1, Acquisition, Fort Lauderdale–Hollywood International Airport, Commercial property, Financial services

Slate Asset Management (Slate), a global alternative investment platform targeting real assets, announced today that Slate Real Estate Capital has closed a $14.9 million senior loan facility provided to AD1 Global (AD1) to refinance the Tru by Hilton Hotel (the hotel) located in Dania Beach, Florida.

Key Points: 
  • Slate Asset Management (Slate), a global alternative investment platform targeting real assets, announced today that Slate Real Estate Capital has closed a $14.9 million senior loan facility provided to AD1 Global (AD1) to refinance the Tru by Hilton Hotel (the hotel) located in Dania Beach, Florida.
  • The hotel is also in close proximity to the Port Everglades, one of the top three cruise ports in the world, and Dania Beach, a popular tourist destination.
  • In January, Slate Real Estate Capital closed a $16.5 million bridge loan provided to AD1 to refinance the Wyndham Garden Hotel in Dania Beach, Florida.
  • Slate is an active lender through its real estate credit platform, Slate Real Estate Capital, which provides transitional capital and flexible liquidity to strong sponsors and assets across the commercial real estate industry.

ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product Portfolio

Retrieved on: 
Wednesday, April 6, 2022
Health, Fitness & Nutrition, Research, Pharmaceutical, Science, Biotechnology, An Act to exempt a particular class of securities from the Securities and Exchange Act, Tru, Company, NR, NAD, NASDAQ, Grain boundary strengthening, Nutrient, Fermentation, Absorption, Multimedia, ChromaDex, Research, SEC, CEO, Security (finance), Western pattern diet, Securities Act of 1933, Fruit, Zinc, Ageing, Vegetable, Drug Quality and Security Act, Maintenance, Curcumin, Annual report, D3, Bureau of Oceans and International Environmental and Scientific Affairs, Vaccine, Dietary supplement, Nicotinamide riboside, RD

View the full release here: https://www.businesswire.com/news/home/20220406005154/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220406005154/en/
    ChromaDex Launches New Product Innovation: Tru Niagen Immune (Photo: Business Wire)
    Our community asked for a holistic daily immune supplement, and we listened to what they had to say.
  • Tru Niagen Immune features an all-in-one formula with best-in-class and scientifically supported ingredients that work together, said Rob Fried, CEO of ChromaDex.
  • Tru Niagen Immune is intended to be a companion to Tru Niagen, and it is recommended that both products be taken together for additional NAD+ support.
  • Tru Niagen and Tru Niagen Immune are life-changing and I believe that if youre going to take any supplement, this routine should be number one.

Amarillo Based KAMP Hotels Growing at a Rapid Pace

Retrieved on: 
Tuesday, November 30, 2021
Season, Aimbridge Hospitality, Growth, Time, Tru, Travel, KAMP, Hilton Worldwide, City, Hotel

AMARILLO, Texas, Nov. 30, 2021 /PRNewswire/ -- KAMP Hotels and Thirty-Nine 23 Management are excited to announce their most recent acquisitions and rapid expansion of their hotel holdings.

Key Points: 
  • AMARILLO, Texas, Nov. 30, 2021 /PRNewswire/ -- KAMP Hotels and Thirty-Nine 23 Management are excited to announce their most recent acquisitions and rapid expansion of their hotel holdings.
  • KAMP Hotels acquired the Tru by Hilton Amarillo West in July.
  • "Completing two acquisitions in a short period of time is a lot of work," said Kevin Nelson of KAMP Hotels.
  • KAMP now owns and operates 307 hotel rooms in Amarillo and Lubbock, including the My Place Hotel - Amarillo West/Medical Center and the My Place Hotel - Lubbock.

ChromaDex Corporation Reports Third Quarter 2021 Financial Results

Retrieved on: 
Wednesday, November 3, 2021
Biotechnology, Pharmaceutical, Health, Science, EBITDA, Research, Securities Act of 1933, Investor relations, GAAP, Ataxia, Adjustment, Twitter, Partnership, Patient, ChromaDex, NASDAQ, Replay, Antibody, SEC, Conference, Clinical trial, Annual report, NR, Marketing, NAD, Company, Investment, Ageing, Webcast, CEO, Growth, Awareness, News, Tru, Risk, Population, Securities Exchange Act of 1934, Molecular Systems Biology, Animal, Pharmaceutical industry, Aquaculture, Bookkeeping

ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the third quarter of 2021.

Key Points: 
  • ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the third quarter of 2021.
  • Net loss was $(8.9) million or $(0.13) per share, a decline of $0.06 per share from the prior year quarter.
  • Results of operations for the three months ended September 30, 2021
    For the three months ended September 30, 2021 (Q3 2021), ChromaDex reported net sales of $17.3 million, up $3.1 million or 22% compared to the third quarter of 2020 (Q3 2020).
  • Such statements include the quotation from ChromaDexs Chief Executive Officer, and statements related to the companys 2021 financial outlook.

ChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland China

Retrieved on: 
Wednesday, September 29, 2021
Other Retail, Other Health, Health, General Health, Specialty, Women, Seniors, Men, Retail, Fitness & Nutrition, Consumer, Ministry of Social Affairs, Securities Act of 1933, Partnership, Watsons, Nicotinamide mononucleotide, Risk, Annual report, Drug Quality and Security Act, State, Economy, Ageing, NASDAQ, Therapeutic Goods Administration, Sale, FDA, NR, JD, National Bureau of Asian Research, Central China, TGA, Sinopharm Group, SEC, State-owned Assets Supervision and Administration Commission, Marketing, SASAC, Royal commission, Industry, Company, WeChat, Health Canada, State Council, Tru, Research, National Bureau of Statistics of China, European Commission, NMN, ChromaDex, Securities Exchange Act of 1934, United Nations Department of Economic and Social Affairs, NAD, Pharmaceutical industry

ChromaDex Corp. (NASDAQ: CDXC) announced today a partnership with Sinopharm Xingsha Pharmaceuticals (Xiamen) Co., Ltd. (Sinopharm Xingsha) to conduct cross-border sales of Tru Niagen in mainland China.

Key Points: 
  • ChromaDex Corp. (NASDAQ: CDXC) announced today a partnership with Sinopharm Xingsha Pharmaceuticals (Xiamen) Co., Ltd. (Sinopharm Xingsha) to conduct cross-border sales of Tru Niagen in mainland China.
  • Sinopharm Xingsha is a subsidiary of Sinopharm Group, with businesses including pharmaceutical manufacturing, marketing and distribution of drugs, and food supplements and healthcare products.
  • Sinopharm Xingsha and ChromaDex will also collaborate to secure Health Food Registration in China.
  • ChromaDex delivers Niagen as the sole active ingredient in its consumer product Tru Niagen available at www.truniagen.com and through partnerships with global retailers and distributors.

DGAP-News: GAIA GROW PROVIDES UPDATE ON TRU EXTRACTS R&D LICENSE APPLICATION AND PRODUCT DEVELOPMENT

Retrieved on: 
Thursday, September 23, 2021
Gaia, Canadian Securities Exchange, News, Research, Failure, GAIA, The Company, CSE, DGAP, TRU, Development, YouTube, Quality control, QC, CEO, Legislation, Company, Health Canada, Research and development, Cannabis, Tru, QA, R, Forward-looking statement, Space food, Government, Industry, Security (finance), Pharmaceutical industry, Cryptocurrency

The licensing process is considered an amendment to the existing licenses in place and should be approved within a few weeks.

Key Points: 
  • The licensing process is considered an amendment to the existing licenses in place and should be approved within a few weeks.
  • These applications are for TRU's own products as well as for sub-tenants Leaf and Mark and Spaced Food.
  • Gaia Grow is an Alberta-based vertically-integrated licensed hemp company with subsidiaries licensed for cannabis and hemp processing, extraction, product formulation, novel product development and cannabis retail.
  • Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

Tru Independence Enhances Cybersecurity Protection For Financial Advisors By Joining Forces With Armorblox

Retrieved on: 
Tuesday, August 24, 2021
Cloud, Industry, Computer security, RIAS, Boston Consulting Group, API, Tru, CA, General Catalyst, Marketing, Language, Forbes, Entrepreneurship, NLU, Natural language, Compliance, CEO, Organization, IBM, PII, BEC, Attack, PCI, COVID-19, Financial adviser, Online shopping

Cybersecurity has always been essential to the wealth management industry, especially as advanced technologies become more prevalent in everyday practices.

Key Points: 
  • Cybersecurity has always been essential to the wealth management industry, especially as advanced technologies become more prevalent in everyday practices.
  • "We are thrilled to be able to offer top of the line cybersecurity to our advisors with Armorblox," said tru Independence Chief Operating Officer, Gary Bonner.
  • With data attacks increasing in frequency, we want our advisors to feel protected with Armorblox and have a strong sense of security."
  • Through this agreement, tru advisors will have access to enterprise-grade security from Armorblox, including protection against data breaches with inbound email protection, email account compromise detection, outbound email protection, and abuse mailbox remediation.

TRU Precious Metals Completes Purchase of South Woods Lake Claims at Golden Rose Project

Retrieved on: 
Wednesday, July 21, 2021
Dixons Carphone, Truphone, Tru, Software, Telecommunications, Mobile phones

Fredericton, New Brunswick--(Newsfile Corp. - July 21, 2021) - TRU Precious Metals Corp. (TSXV: TRU) (OTCQB: TRUIF) (FSE: 706) ("TRU" or the "Company") is pleased to announce that, further to its press release dated July 8, 2021, it has completed the purchase of a claims package (the "Purchased Assets") contiguous with the Company's flagship Golden Rose Project.

Key Points: 
  • Fredericton, New Brunswick--(Newsfile Corp. - July 21, 2021) - TRU Precious Metals Corp. (TSXV: TRU) (OTCQB: TRUIF) (FSE: 706) ("TRU" or the "Company") is pleased to announce that, further to its press release dated July 8, 2021, it has completed the purchase of a claims package (the "Purchased Assets") contiguous with the Company's flagship Golden Rose Project.
  • All common shares of TRU issued as consideration for the Purchased Assets are subject to a hold period expiring four months and one day from July 21, 2021.
  • About TRU Precious Metals Corp.
    TRU has assembled a portfolio of 5 gold exploration properties in the highly prospective Central Newfoundland Gold Belt.
  • The Company has an option with a subsidiary of TSX-listed Altius Minerals Corporation to purchase 100% of the Golden Rose Project, located along the deposit-bearing Cape Ray - Valentine Lake Shear Zone.

Functional Unemployment Drops While Overall Earnings Decline, According to LISEP

Retrieved on: 
Friday, July 16, 2021
Economy, Unemployment, Inflation, Tru, Economics

But unfortunately for the middle class, real median earnings as a whole fell, with earners at the 75th percentile losing more than 2.0%.

Key Points: 
  • But unfortunately for the middle class, real median earnings as a whole fell, with earners at the 75th percentile losing more than 2.0%.
  • LISEP issued its monthly True Rate of Unemployment (TRU) for June in conjunction with the quarterly True Weekly Earnings (TWE) report for the second quarter of 2021.
  • TWE, an overall measure of inflation adjusted median weekly earnings, tells yet a different story.
  • LISEP issues TRU onetotwo weeks following the release of the BLS unemployment report, which occurs on the first Friday of each month.